Hyperactivity News and Research

RSS

Findings may suggest new therapeutic target to combat memory loss in aging, Alzheimer's disease

Northwestern Medicine scientists have examined activity in a little-studied part of the brain associated with memory and found for the first time the reason that neurons there become more active in old age, findings that may suggest a new target for future therapies to combat memory loss in aging and Alzheimer's disease.

23 Sep 2015

Research examines effects of antidepressant use on health of mother and child

The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).

16 Sep 2015

Researchers receive NIH grant to test novel drug therapy for Alzheimer's dementia

Johns Hopkins University researchers have received an estimated $7.5 million National Institutes of Health grant to clinically test what would be the first treatment to prevent or delay the onset of Alzheimer's dementia.

16 Sep 2015

Why do we sleep? An interview with Professor Wisden

It is true that we still do not know why we need to sleep every night. Sleep is essential for health. We have to do it every day. But nobody yet knows why. This fact amazes me.

8 Sep 2015

Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Ex-prisoners with common psychiatric disorders such as bipolar disorder (manic-depressive disorder) and alcohol and drug abuse are substantially more likely to commit a violent crime after release than other prisoners, according to new research published in The Lancet Psychiatry journal.

4 Sep 2015

Lannett enters into definitive agreement to purchase KU for $1.23 billion

Lannett Company, Inc. today announced that it has signed a definitive agreement to purchase Kremers Urban Pharmaceuticals Inc., the U.S. specialty generic pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A., for $1.23 billion, plus potential contingency payments.

3 Sep 2015

New NIH grants support research that combines DNA sequence information and electronic medical records

A dozen awards from the National Institutes of Health will support research that incorporates DNA sequence information into electronic medical records. The goal of research conducted by the Electronic Medical Records and Genomics (eMERGE) network is to better understand the genomic basis of disease and to tailor medical care to individual patients based on their genomic differences.

2 Sep 2015

Pitt researchers identify molecular mechanisms behind resilience to tinnitus, possible drug therapy

Researchers have identified in an animal model the molecular mechanisms behind resilience to noise-induced tinnitus and a possible drug therapy that could reduce susceptibility to this chronic and sometimes debilitating condition. The findings by a team from the University of Pittsburgh School of Medicine were published online in the journal eLife.

28 Aug 2015

Young adults diagnosed with ADHD in adolescence show differences in brain structure, memory

Young adults diagnosed with attention deficit/hyperactivity disorder (ADHD) in adolescence show differences in brain structure and perform poorly in memory tests compared to their peers, according to new research from the University of Cambridge, UK, and the University of Oulu, Finland.

27 Aug 2015

Study provides insight into how the ability to inhibit an action affects attention and memory

You're driving on a busy road and you intend to switch lanes when you suddenly realize that there's a car in your blind spot. You have to put a stop to your lane change -- and quickly. A new study by Duke University researchers suggests that this type of scenario makes a person less likely to remember what halted the action -- for example, the make and model of the car in the blind spot.

27 Aug 2015

Researchers awarded $6.4 million grant to identify causes of neurodevelopmental disorders in children with CHDs

As advances in medicine are giving rise to growing numbers of children who are surviving severe heart defects, a phenomenon is emerging that is catching parents and healthcare providers off-guard. Over half of these children also have a seemingly unrelated disability: neurodevelopmental disorders. Some have severe cognitive and motor deficits that arise early.

25 Aug 2015

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Intrexon Corporation, a leader in synthetic biology, and Synthetic Biologics, Inc., a clinical-stage company focused on developing therapeutics to protect the microbiome while targeting pathogen-specific diseases, today announced an Exclusive Channel Collaboration (ECC) to pursue the development and commercialization of novel biotherapeutics for the treatment of patients with phenylketonuria (PKU), a serious and debilitating metabolic disorder.

10 Aug 2015

Brili launches new app for families with ADHD kids at 2015 APA Convention

Brili Inc., the company that creates technology to help kids succeed, today launches an app for families challenged with ADHD at the 2015 APA Convention. The conference will feature over thirty different presentations focused on ADHD, indicative of the pervasiveness of a condition affecting millions of children. Brili will be showcasing how their app can help families manage the challenges of ADHD during the hectic and challenging back to school crunch.

7 Aug 2015

Drug treatment mitigates injury risk in ADHD children

Study findings show the importance of pharmacological treatment for attention deficit/hyperactivity disorder in ameliorating the increased risk of injuries associated with the condition.

4 Aug 2015

Ironshore partners with Restore Health to participate in HLD-200 clinical trial to treat ADHD

Ironshore Pharmaceuticals & Development, Inc. has signed an agreement with Restore Health, a company specializing in personalized medicine, to participate in the fulfillment of a double-blind clinical trial, designed to evaluate the safety and efficacy of HLD-200, a new drug in development to treat Attention-deficit/hyperactivity disorder (ADHD).

4 Aug 2015

Study: Positive reinforcement improves performance of ADHD kids on certain cognitive tasks

A little recognition for a job well done means a lot to children with Attention Deficit/Hyperactivity Disorder (ADHD) - more so than it would for typically developing kids.

31 Jul 2015

Mice without specific brain chemical develop characteristics similar to bipolar disorder, shows study

Mice that have a particular brain chemical switched off become hyperactive and sleep for just 65 per cent of their normal time.

29 Jul 2015

Recycling older electronic devices increases exposure to lead, creates health concern

The disposal and recycling of electronic devices has increased exposure to lead and other toxicants and created "an emerging health concern," according to a pediatrician who directs the Environmental Health and Lead Clinic at Cincinnati Children's Hospital Medical Center.

29 Jul 2015

Mothers with chemical intolerances more likely to have children with ASD or ADHD

A new study from The University of Texas Health Science Center at San Antonio found that mothers with chemical intolerances are two to three times more likely than other women to have a child with autism spectrum disorder (ASD) or attention deficit hyperactivity disorder (ADHD).

21 Jul 2015

Cognitive training can help reduce civilian shooting casualties

Although firing a gun seems like one action, it is made up of many smaller decisions and movements that require coordination between multiple brain areas. The sudden decision to not shoot, called 'response inhibition,' is critical when someone innocent comes into the line of fire. That is what soldiers in war experience when they're about to pull the trigger and then realize that their target is a civilian or an ally. Or when a law enforcement officer realizes that a person they thought was armed and dangerous is actually an innocent bystander.

17 Jul 2015

Hyperactivity News and Research

Findings may suggest new therapeutic target to combat memory loss in aging, Alzheimer's disease

Research examines effects of antidepressant use on health of mother and child

Researchers receive NIH grant to test novel drug therapy for Alzheimer's dementia

Why do we sleep? An interview with Professor Wisden

Ex-prisoners with common psychiatric disorders more likely to commit violent crimes after release

Lannett enters into definitive agreement to purchase KU for $1.23 billion

New NIH grants support research that combines DNA sequence information and electronic medical records

Pitt researchers identify molecular mechanisms behind resilience to tinnitus, possible drug therapy

Young adults diagnosed with ADHD in adolescence show differences in brain structure, memory

Study provides insight into how the ability to inhibit an action affects attention and memory

Researchers awarded $6.4 million grant to identify causes of neurodevelopmental disorders in children with CHDs

Intrexon, Synthetic Biologics form ECC to develop and commercialize novel biotherapeutics for phenylketonuria

Brili launches new app for families with ADHD kids at 2015 APA Convention

Drug treatment mitigates injury risk in ADHD children

Ironshore partners with Restore Health to participate in HLD-200 clinical trial to treat ADHD

Study: Positive reinforcement improves performance of ADHD kids on certain cognitive tasks

Mice without specific brain chemical develop characteristics similar to bipolar disorder, shows study

Recycling older electronic devices increases exposure to lead, creates health concern

Mothers with chemical intolerances more likely to have children with ASD or ADHD

Cognitive training can help reduce civilian shooting casualties

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News